28^th World Nanotechnology Congress

Research on Covid-19 Medicine and Vaccine

Coronavirus disease 2019 is an endemic vascular and respiratory disease which is an on-going pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019. Currently, 19 network members engaged in research and development of COVID-19 vaccines, using six principal technology platforms and it is identified in humans. World Health Organization complies with international moderations and mechanisms to distribute vaccines across borders. The use of actual manufacturing, fill-finish and distribution proficiency can support an efficient roll-out of vaccines against COVID-19. A vaccine for an infectious disease has never before been composed in less than several years, and no vaccine exists for preventing a coronavirus infection in humans.